1.Immune-Inflammatory Mechanisms and Traditional Chinese Medicine Intervention Strategies of Colorectal Cancer Cachexia Based on the "Reinforcing Healthy Qi and Dispelling Pathogen" Theory
Zhenming XIE ; Wenyu WU ; Wenqi HUANG ; Huili SHUI ; Bing YANG ; Dongxin TANG
Journal of Traditional Chinese Medicine 2026;67(12):1267-1271
This paper explores the immune-inflammatory regulatory mechanism of colorectal cancer cachexia and corresponding traditional Chinese medicine (TCM) intervention strategies based on the TCM theory of reinforcing healthy qi and dispelling pathogenen. It is proposed that depletion of healthy qi is the root cause of colorectal cancer cachexia, while cancer toxins exuberance is the symptomatic manifestation of the disease, and failure of the spleen and stomach is the core pathogenesis. In terms of treatment, a TCM treatment system is constructed based on the principles of reinforcing healthy qi to consolidate the foundation and regulate immunity, and dispelling pathogen to remove toxins and alleviate inflammation. The system clarifies the healty qi-reinforcing method as fortifying spleen and boosting qi to enhance immune function, and nourishing blood and enriching yin to consolidate yin essence and healthy qi. It also emphasizes the pathogen-dispelling method as clearing heat and removing toxins to regulate the secretion of inflammatory cytokines, and promoting blood circulation and resolving stasis to improve the immune microenvironment and microcirculation. This therapeutic approach may provide valuable insights for TCM interventions in colo-rectal cancer cachexia.
2.LIU Shangyi's Experience in Differentiating and Treating Rectal Carcinoma Under the Theory of "Treating Ulcers as Tumors"
Wenqi HUANG ; Bing YANG ; Zhenming XIE ; Jinghui WANG ; Dingxue WANG ; Wenyu WU ; Dongxin TANG ;
Journal of Traditional Chinese Medicine 2026;67(7):716-719
This paper summarizes the experience of professor LIU Shangyi in differentiating and treating rectal carcinoma from the perspective of "treating ulcers as tumors". It is believed that the manifestations of rectal cancer, such as anal itching, cauliflower-like or ulcerative tumors, and bloody stools, are similar to external skin itching, skin ulceration, swelling, and skin bleeding. Therefore, the treatment principles of sores and ulcers department can be applied to treat tumors. Following the diagnostic and treatment approach of dermatology regarding the clinical typical symptoms, for anal itching, the main treatment is to dispel wind and remove dampness, clear heat to relieve itching, using "skin medicinals" such as Difuzi (Fructus Kochiae) and Baixianpi (Cortex Dictamni), as well as wind medicinals such as Shengma (Rhizoma Cimicifugae) and Fangfeng (Radix Saposhnikoviae). For constipation, the method of clearing heat and resolving toxins, unblocking the bowels and discharging heat can be used, commonly using Baitouweng (Radix Pulsatillae), Donglingcao (Herba Rabdosiae Rubescentis) and Dahuang (Radix et Rhizoma Rhei). In terms of mucosal ulcers, it is critical to differentiate between yin and yang; the treatment of yang ulcers should focus on clearing heat and resolving toxins, commonly using modified Xianfang Huoming Beverage (仙方活命饮); for yin ulcers, emphasis should be placed on removing dampness and resolving phlegm, commonly with modified Yiyi Fuzi Baijiang Powder (薏苡附子败酱散). For bloody stool, differentiation is made between deficiency and excess, with the use of Diyu (Radix Sanguisorbae) and Huaihua (Flos Sophorae) for excess syndrome to cool and stop blee-ding, and both herbs dry-fried until charred combined with liver-tonifying medicinals for deficiency syndrome
3.Pathogenesis of Diabetic Nephropathy and Traditional Chinese Medicine Intervention Based on Signaling Pathways: A Review
Yaohong LU ; Chenjie HUANG ; Wenqi YUAN ; Haidong ZHOU ; Gengxin LIU ; Gedi ZHANG ; Ziyou YAN
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(11):287-299
Diabetic nephropathy (DN) is one of the most common and severe microvascular complications of diabetes, with a complex pathogenesis involving immune inflammatory responses, oxidative stress, apoptosis, glomerulosclerosis, renal interstitial fibrosis, and other pathological processes. In recent years, numerous animal or cell model experiments have revealed that the transforming growth factor-β (TGF-β)/mothers against decapentaplegic homolog (Smad), phosphoinositide 3-kinase (PI3K)/ protein kinase B (Akt)/mammalian target of rapamycin (mTOR), mitogen-activated protein kinase (MAPK), AMP-activated protein kinase (AMPK), nuclear factor-κB (NF-κB), Janus kinase (JAK)/signal transducer and activator of transcription (STAT), neurogenic locus notch homolog protein (Notch), nuclear factor E2-related factor 2 (Nrf2), secretory glycoprotein (Wnt)/β-catenin, and other classical signaling pathways play important roles in the occurrence and development of DN. Traditional Chinese medicines, as natural drugs, possess characteristics such as multiple components, multiple targets, and few adverse reactions, demonstrating unique advantages in regulating the aforementioned signaling pathways and improving renal pathological changes. This review summarized recent research progress on the intervention of DN through the regulation of the aforementioned signaling pathways by single compounds and formulas of traditional Chinese medicine, focusing on their mechanisms of action in regulating immune inflammatory responses, inhibiting renal fibrosis, oxidative stress, improving metabolic disorders, and other aspects. The aim is to provide theoretical references for a deeper understanding of the modern pharmacological basis and clinical application of traditional Chinese medicine in the treatment of DN.
4.Mechanism prediction and verification of Xihuang pill against diffuse large B-cell lymphoma
Ruyi HUANG ; Jinyu LI ; Wenqi LIN ; Xin JIANG ; Yanling CHEN ; Weikun HUANG ; Lin YANG
China Pharmacy 2026;37(2):161-167
OBJECTIVE To investigate the mechanism of Xihuang pill (XHP) against diffuse large B-cell lymphoma (DLBCL). METHODS The active ingredients of XHP and potential therapeutic targets for DLBCL were identified using TCMSP, GeneCards and DisGeNET databases. Protein-protein interaction networks were constructed using the String database and Cytoscape software to screen core components and core targets. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were then performed. The clinical relevance of core targets was analyzed using the GEPIA and PanCanSurvPlot databases. Molecular docking and molecular dynamics (MD) simulation were conducted to verify the interactions between core components and core targets, and the binding free energy was calculated using the molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) method. The effects of XHP on DLBCL and the related molecular mechanisms were validated using CCK-8 assay, flow cytometry and Western blot. RESULTS Network pharmacology analysis identified 108 active ingredients of XHP and 410 potential therapeutic targets for DLBCL. Six core components (e.g., 17 beta-estradiol, quercetin) and ten core targets [e.g., tumor protein 53 (TP53), proto-oncogene tyrosine-protein kinase Src (SRC)] were obtained. Enrichment analysis indicated that the anti-DLBCL effects of XHP were primarily associated with the apoptotic signaling pathway, the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway and so on. Clinical correlation analysis revealed that TP53 and SRC expression were significantly up-regulated in DLBCL tissues and associated with poor patient prognosis (P<0.05). Molecular docking, MD simulations and MM-PBSA calculations confirmed that the SRC-quercetin complex had a mail:stronger and more stable binding affinity. In vitro experiments demonstrated that XHP concentration-dependently inhibited the proliferation of DLBCL cells; compared with control group, XHP medium- and high-dose groups could significantly induce the apoptosis of SU-DHL2 and SU-DHL4 cells, and significantly down- regulated the expressions of SRC protein, phosphorylated (p)-PI3K/PI3K and p-Akt/Akt in SU-DHL4 cells (P<0.05). CONCLUSIONS XHP may inhibit the proliferation and induce the apoptosis of DLBCL cells by regulating the SRC/PI3K/Akt signaling pathway.
5.Pathogenesis and Treatment Strategies of Colorectal Cancer Mediated by Circadian Rhythm Disorder:from the Perspective of Traditional Chinese Medicine Chronomedicine
Zhenming XIE ; Wenqi HUANG ; Wenyu WU ; Huibin CHEN ; Bing YANG ; Dongxin TANG
Journal of Traditional Chinese Medicine 2026;67(16):1798-1803
Based on the theory of traditional Chinese medicine (TCM) chronomedicine, this paper explores the pathogenesis and treatment strategies of colorectal cancer mediated by circadian rhythm disorders. It is believed that the imbalance of yin and yang is isomorphic to the disorder of biological clock genes, which is the root cause of the disease. The disharmony of ying and wei (营卫) corresponds to the imbalance of immunity and metabolism, which is the pivot of the disease. The disorder of qi movement is related to the imbalance of intestinal barrier, which is the manifestation of the disease. Accordingly, relevant strategies are proposed, including chronochemotherapy regimen that aligns with biological rhythms to enhance efficacy and reduce toxicity, acupuncture based on the ebb and flow of midnight and midday which selects acupoints along meridians to harmonize qi and blood, and a timed medication strategy that matches the disease mechanism by administering drugs at optimal times. These strategies aim to deepen the understanding of the pathogenesis of colorectal cancer mediated by circadian rhythm disorders from the perspective of TCM chronomedicine, thereby providing new ideas for clinical practice.
6.Mechanism of "Inflammation-Metabolism-Immunity" Regulation in Colorectal Cancer Cachexia Based on Theory of "Spleen Functions as Wei (卫) Qi" and Therapeutic Strategy from the Spleen
Zhenming XIE ; Wenyu WU ; Wenqi HUANG ; Jia DENG ; Huili SHUI ; Ailing LIANG ; Dongxin TANG
Journal of Traditional Chinese Medicine 2026;67(19):2068-2072
Based on the theory of "spleen functions as wei (卫) qi", this paper discusses the mechanism of "inflammation-metabolism-immunity" regulation in colorectal cancer cachexia and the therapeutic strategy. It is proposed that spleen deficiency with failure in transportation, leading to the maldistribution of wei (卫) qi and pathogenic constraint transforming into fire, is the source of inflammation. Spleen deficiency with failure in transportation, leading to the maldistribution of subtle essences and loss of nourishment to the physical body, is the root of metabolic depletion. Spleen deficiency with failure in transportation, leading to wei qi depletion and healthy qi decline, is the cause of immune impairment. Accordingly, a spleen-centered strategy of fortifying the spleen and restoring its defensive function is established. The specific therapeutic approaches include fortifying the spleen and boosting qi, restoring defensive function and securing the exterior to replenish the source of wei qi, with modified Sijunzi Decoction (四君子汤), fortifying the spleen and removing toxin, resolving phlegm and stasis to restrain exuberant internal toxin and constrained fire, with modified Baitouweng Decoction (白头翁汤), activating the spleen and harmonizing the stomach, promoting the transportation and distribution of food essence to correct nutritional and metabolic disorders, with modified Xiangsha Liujunzi Decoction (香砂六君子汤), and fortifying the spleen and nourishing the kidney, replenishing primordial qi and consolidating the root to restore immune competence, with Buzhong Yiqi Decoction (补中益气汤) and Zuogui Beverage (左归饮) as the basic prescription.
7.Mechanism of "Inflammation-Metabolism-Immunity" Regulation in Colorectal Cancer Cachexia Based on Theory of "Spleen Functions as Wei (卫) Qi" and Therapeutic Strategy from the Spleen
Zhenming XIE ; Wenyu WU ; Wenqi HUANG ; Jia DENG ; Huili SHUI ; Ailing LIANG ; Dongxin TANG
Journal of Traditional Chinese Medicine 2026;67(19):2068-2072
Based on the theory of "spleen functions as wei (卫) qi", this paper discusses the mechanism of "inflammation-metabolism-immunity" regulation in colorectal cancer cachexia and the therapeutic strategy. It is proposed that spleen deficiency with failure in transportation, leading to the maldistribution of wei (卫) qi and pathogenic constraint transforming into fire, is the source of inflammation. Spleen deficiency with failure in transportation, leading to the maldistribution of subtle essences and loss of nourishment to the physical body, is the root of metabolic depletion. Spleen deficiency with failure in transportation, leading to wei qi depletion and healthy qi decline, is the cause of immune impairment. Accordingly, a spleen-centered strategy of fortifying the spleen and restoring its defensive function is established. The specific therapeutic approaches include fortifying the spleen and boosting qi, restoring defensive function and securing the exterior to replenish the source of wei qi, with modified Sijunzi Decoction (四君子汤), fortifying the spleen and removing toxin, resolving phlegm and stasis to restrain exuberant internal toxin and constrained fire, with modified Baitouweng Decoction (白头翁汤), activating the spleen and harmonizing the stomach, promoting the transportation and distribution of food essence to correct nutritional and metabolic disorders, with modified Xiangsha Liujunzi Decoction (香砂六君子汤), and fortifying the spleen and nourishing the kidney, replenishing primordial qi and consolidating the root to restore immune competence, with Buzhong Yiqi Decoction (补中益气汤) and Zuogui Beverage (左归饮) as the basic prescription.
8.Value of lung ultrasound monitoring in the clinical diagnosis and treatment of mycoplasma pneumoniae pneumonia in children
Lei ZUO ; Yi HUANG ; Lian XUE ; Meng JU ; Wenqi CUI ; Sihan WANG ; Dan SU ; Xin ZHANG
Chinese Journal of Ultrasonography 2025;34(3):203-209
Objective:To evaluate the lung ultrasound characteristics of mycoplasma pneumoniae pneumonia in children and to investigate the value of lung ultrasound monitoring in clinical diagnosis and treatment.Methods:A retrospective analysis of 62 children with mycoplasma pneumoniae pneumonia admitted to Xi'an Chest Hospital from 7 November to 30 November 2023 was performed,and the characteristic parameters of bedside lung ultrasound and their related clinical data were collected. Pathological lung ultrasound features such as interrupted pleural line,well-spaced B-lines,coalescent B-lines,small subpleural patchy pulmonary consolidation,large pulmonary consolidation and pleural effusion in 12 scan areas of both lungs were observed. The maximum upper and lower diameters,right and left diameters,and anterior and posterior diameters of the large pulmonary consolidations were measured,and the changes in the above signs before and after treatment were measured and compared.Results:In sixty-two children with mycoplasma pneumoniae pneumonia,including 32 males and 30 females,with a mean age of(8.18 ± 2.05)years old and a mean hospital stay of(8.79 ± 2.93)days,lung ultrasound showed interrupted pleural line,well-spaced B-lines,coalescent B-lines,small subpleural patchy pulmonary consolidation,large pulmonary consolidation and pleural effusion,with the incidence of 93.5%(58 /62),33.9%(21/62),32.3%(20/62),59.7%(37/62),66.1%(41/62)and 17.7%(11/62),respectively,in which the large pulmonary consolidations presented rich blood supply were more common in the L6 and L4 areas,while the pleural effusions were more common in the L6 area.The signs of interrupted pleural line,coalescent B-lines,large pulmonary consolidation and pleural effusion were significantly improved after treatment compared with before treatment(all P<0.05). The upper and lower diameters,left and right diameters,and anterior and posterior diameters of large pulmonary consolidations were significantly reduced after treatment compared with before treatment[(4.19 ± 2.42)cm vs.(2.84 ± 2.31)cm, t=2.613, P=0.011;(2.80 ± 1.82)cm vs.(1.96 ± 1.62)cm, t=2.226, P=0.029;(3.41 ± 2.11)cm vs.(2.12 ± 1.82)cm, t=2.972, P=0.004].With the process of treatment,the dynamic observation of lung ultrasound showed that the well-spaced B-lines/coalescent B-lines gradually decreased until they completely disappeared or a small number of B-lines remained,and the area of the large pulmonary consolidation showed a dynamic downward trend(all P<0.001),and the area of large pulmonary consolidations gradually decreased until they completely disappeared or only small subpleural patchy pulmonary consolidations and well-spaced/coalescent B-lines remained,and at the same time,the pleural effusion gradually absorbed until it disappeared. Conclusions:Lung ultrasound can detect the distribution area of lung lesions,morphology and blood supply characteristics of children with mycoplasma pneumoniae pneumonia,as well as the dynamic changes after treatment,and lung ultrasound can dynamically monitor and evaluate the progression and regression of the disease in real time,providing a reliable imaging evidence for clinical practice.
9.Clinical research advances in nasal inflammatory disease: highlights from the 2025 European Academy of Allergy and Clinical Immunology Congress
Wenqi LUO ; Zhiqun HUANG ; Jing YE
Chinese Journal of Preventive Medicine 2025;59(9):1434-1438
From June 13th to 16th, 2025, the European Academy of Allergy and Clinical Immunology annual meeting was successfully held in Glasgow, UK. The conference attracted over 8 000 scholars and experts from around the world, becoming the largest global event in the fields of allergy, asthma, and clinical immunology. The theme of the conference,"Breaking boundaries in Allergy, Asthma and Clinical Immunology: Integrating Planetary Health for a Sustainable Future" focused on the close relationship between environmental changes and allergic diseases. As climate change continues to intensify, the pathogenesis and prevention strategies for allergic diseases have garnered widespread attention. In this meeting, allergic rhinitis and chronic rhinosinusitis were major topics of discussion, and the research advancements presented provided valuable insights for future clinical treatments.
10.Clinical research advances in nasal inflammatory disease: highlights from the 2025 European Academy of Allergy and Clinical Immunology Congress
Wenqi LUO ; Zhiqun HUANG ; Jing YE
Chinese Journal of Preventive Medicine 2025;59(9):1434-1438
From June 13th to 16th, 2025, the European Academy of Allergy and Clinical Immunology annual meeting was successfully held in Glasgow, UK. The conference attracted over 8 000 scholars and experts from around the world, becoming the largest global event in the fields of allergy, asthma, and clinical immunology. The theme of the conference,"Breaking boundaries in Allergy, Asthma and Clinical Immunology: Integrating Planetary Health for a Sustainable Future" focused on the close relationship between environmental changes and allergic diseases. As climate change continues to intensify, the pathogenesis and prevention strategies for allergic diseases have garnered widespread attention. In this meeting, allergic rhinitis and chronic rhinosinusitis were major topics of discussion, and the research advancements presented provided valuable insights for future clinical treatments.

Result Analysis
Print
Save
E-mail